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ORIGINAL ARTICLE
Confounding Underlies the Apparent
Month of Birth Effect in Multiple Sclerosis
Barnaby Fiddes, MRCP,1 James Wason, PhD,2 Anu Kemppinen, PhD,1
Maria Ban, PhD,1 Alastair Compston, FRCP, PhD,1 and
Stephen Sawcer, FRCP, PhD1
Objective: Several groups have reported apparent association between month of birth and multiple sclerosis. We
sought to test the extent to which such studies might be confounded by extraneous variables such as year and place
of birth.
Methods: Using national birth statistics from 2 continents, we assessed the evidence for seasonal variations in birth rate
and tested the extent to which these are subject to regional and temporal variation. We then established the age and re-
gional origin distribution for a typical multiple sclerosis case collection and determined the false-positive rate expected
when comparing such a collection with birth rates estimated by averaging population-specific national statistics.
Results: We confirm that seasonality in birth rate is ubiquitous and subject to highly significant regional and temporal
variations. In the context of this variation we show that birth rates observed in typical case collections are highly
likely to deviate significantly from those obtained by the simple unweighted averaging of national statistics. The sig-
nificant correlations between birth rates and both place (latitude) and time (year of birth) that characterize the gen-
eral population indicate that the apparent seasonal patterns for month of birth suggested to be specific for multiple
sclerosis (increased in the spring and reduced in the winter) are expected by chance alone.
Interpretation: In the absence of adequate control for confounding factors, such as year and place of birth, our analyses
indicate that the previous claims for association of multiple sclerosis with month of birth are probably false positives.
ANN NEUROL 2013;73:714–720
Case–control studies are frequently employed as ameans of testing for association between a disease of
interest and candidate etiological risk factors. However,
despite the apparent simplicity of this approach, spurious
results are not uncommon1 and may easily arise if study
design fails to avoid bias in the selection of study sub-
jects.2 Because practical considerations mean that it is
rarely possible to recruit cases and controls in an identi-
cal manner, it is usual to select study subjects from
within a well-defined population, where exposure to the
risk factor of interest is assumed to be distributed homo-
genously. However, bias may arise if the assumption of
homogeneity is invalid, and subgroups that differ in the
frequency of the candidate risk factor are concealed
within the population from which cases and controls are
drawn. In this situation, differences in ascertainment
may result in biased representation of the relevant sub-
groups among the samples of cases and controls, thereby
creating an apparent difference in exposure and a false-
positive association. Furthermore, even if cases and con-
trols are randomly selected from the whole population,
false-positive associations may still occur if the fre-
quency of the disease and of the candidate risk factor
correlate across these subgroups (see the example from
genetics below).3,4 Counterintuitively, such false-positive
associations become increasingly more likely as sample
size increases5; but do not occur (irrespective of sample
size) if the study population is homogeneous with
respect either to the frequency of the disease or to the
candidate risk factor.4
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In the analysis of month of birth, researchers have
invariably assumed homogeneity within individual coun-
tries and have therefore felt justified in using averaged
population statistics as controls. Here, we review the evi-
dence that month of birth varies significantly with geo-
graphical location6–8 and over time8–11 in the normal
population and consider the implication of this variation
for case–control studies considering month of birth as a
risk factor for the development of multiple sclerosis.
Subjects and Methods
Using publically available national statistics, we established
year-specific month of birth data sets (the number of births per
month over a calendar year) for multiple years from 17 coun-
tries (Austria, Belgium, Canada, Denmark, Finland, France,
Germany, Greece, Ireland, Italy, the Netherlands, Norway, Por-
tugal, Spain, Sweden, Switzerland, and the United Kingdom),
51 North American regions (50 states and the District of
Columbia), and 10 UK Government Office Regions (Supple-
mentary Information). Data sets were tested for evidence of sea-
sonality by comparison with the expected distribution of births
in each month under the assumption of a uniform birth rate
using a chi-square test (11 df ). The chi-square test was also
used to compare data sets within and between countries. In
comparisons between consecutive years from the same country,
the number of births in February was reduced by 1=29 for leap
years, so that all such comparisons were based on data for 365
days. In these chi-square tests, we took p < 0.05 as evidence
for a statistically significant difference, unless otherwise stated.
To explore these complex data more formally, we used a multi-
nomial logit model,12 which is a generalization of a logistic
regression model that allows for >2 discrete outcomes (see Sup-
plementary Information). We use this method to model how
the probability of an individual being born in each month
depends on different covariates, including latitude and the year
of birth.
We generated a multiple sclerosis month of birth data set
using records from the database we previously established
through our UK nationwide effort to recruit patients for genetic
studies. This database includes 15,765 affected index cases, of
whom information on year and month of birth are available for
12,198 (see Supplementary Information).
To investigate the type I error rate of a typical month of
birth analysis, we estimated the expected month of birth distri-
bution in cases and controls using the UK Government Office
Region data. For the cases, the distribution was weighted
according to the regional prevalence of multiple sclerosis (see
Structure and Risk Factors) and the observed year of birth,
whereas the simple unweighted average was used for the con-
trols. Because this analysis assumes homogeneity within each
region, it is expected to underestimate the type I error rate.
Two types of analyses were considered. First, we mirrored a dis-
covery study, consisting of twelve 2 3 2 contingency tables,
each comparing the number of case and control births in 1
month with the number in the other 11, and with significance
declared if the Pearson chi-square test was significant after Bon-
ferroni correction (p < 0.05=12 5 0.0042). Using the expected
month of birth distribution in cases and controls, we deter-
mined the noncentrality parameter for each of these tests,12 and
thereby calculated the probability of declaring evidence for a
significant effect by chance alone—the type I error rate. The
second analysis mirrored attempts to replicate the pattern previ-
ously suggested for multiple sclerosis,13–16 that is, finding a
nominally significant (p < 0.05) excess of births in March,
April, or May and=or a nominally significant (p < 0.05) deficit
in November, December, or January. In all analyses, the num-
bers of cases and controls were equal.
Results
Given the large number of cultural and biological factors
that influence the timing of birth,6,7 it is perhaps not
surprising that 98% of these 1,344 year- and population-
specific month of birth data sets (824 from Europe and
520 from North America) show statistically significant
evidence for seasonality (variation in birth rate through
the year), the majority (>90%) at extreme levels of sig-
nificance (p < 1026). Considering the variation in birth
rates seen for individual months and applying a Bonfer-
roni correction (so that p < 0.0042 is considered signifi-
cant), we found statistically significant evidence for
seasonality, with excess births in either March, April, or
May and=or reduced births in November, December, or
January, mirroring the pattern described for multiple
sclerosis,13–15 in 97% of European and 48% of North
American data sets (see Supplementary Information).
This apparent difference between continents primarily
results from lower annual birth rates in many of the US
states, which therefore lack the power to demonstrate
observed differences as significant. In continent-specific
pairwise comparisons, month of birth data sets showed
significant differences both within and between popula-
tions (see Supplementary Information and Fig 1); again,
the greatest differences were observed in the spring
(March, April, and May) and winter (November, Decem-
ber, and January). As anticipated, our data confirm the
expected correlations between seasonal birth rates and lat-
itude6,7 and show that these correlations have diminished
over time (see Supplementary Information).8–11 Given
the known latitudinal gradient in the prevalence of mul-
tiple sclerosis, the positive correlation between prevalence
and the probability of being born in the spring and the
negative correlation with the probability of being born in
winter are not unexpected (Fig 2).
To assess correlations within the month of birth
data sets more rigorously, we used a multinomial logit
model, including country as a factor, together with year
of birth and whether that year was a leap year as covari-
ates. Although this model explained only a small
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proportion of the variance in month of birth, the param-
eters representing the effect for each country were all
highly significant, confirming that the distribution of
month of birth differs significantly between countries.
Fitting a second model that included latitude as an addi-
tional factor confirmed that the relationship between
month of birth and latitude is statistically highly
significant.
To test for the presence of regional heterogeneity in
birth rates within individual populations, we considered
440 UK Government Office Region month of birth data
sets (see Supplementary Information). More than 99%
showed statistically significant evidence for seasonality,
with 66% reproducing the pattern described for multiple
sclerosis (statistically significant after Bonferroni correc-
tion); the most marked differences were seen in March
and October. Comparing each Government Office
Region month of birth data set with the set of UK con-
trols employed in 1 influential study13 (n 5 11,502)
confirmed that 61% of these records include at least 1
month in which there is statistically significant evidence
for a difference mimicking the pattern considered charac-
teristic of multiple sclerosis. Even after scaling the Gov-
ernment Office Regions month of birth data sets to an
equivalent size (n 5 11,502), 33% continued to show at
least 1 month with nominally significant evidence.
Conversely, stratifying month of birth data sets into
gender-specific components showed no difference in
birth rates between males and females. This indicates
that mismatching of gender between case collections and
controls is unlikely to confound results, no matter how
extreme the mismatch and irrespective of sample size.
Comparing our sample of 12,198 UK multiple
sclerosis cases with the expected numbers of births per
month (calculated on the basis of a simple unweighted
average across the 67 year-specific UK month of birth
data sets obtained from the UK Office of National Statis-
tics) showed that the greatest excess in births was seen in
March (p 5 0.06) and the greatest deficit in December
(p 5 0.03; see Supplementary Fig S13). Combining
these data with those from northern hemisphere-based
studies purporting to show a month of birth effect in
multiple sclerosis13–15,17 generated a data set comprising
132,241 cases (after excluding duplicates). Comparing
these cases with averaged population-specific month of
birth data reproduces the putative multiple sclerosis pat-
tern if an excess in June (p 5 0.006) and a less
FIGURE 1: Seasonality seen in 3 typical month of birth data
sets. The y-axis shows the average normalized daily birth
rate, and the x-axis shows the months of the year (coded by
their first letter). UK data for 3 years are shown; 1950 (solid
line), 1960 (thick dashed line), and 1970 (thin dashed line).
The rates were calculated allowing for the length of each
month and for leap years, but for simplicity are plotted
assuming the length of each month is equal (1960 was a
leap year, whereas 1950 and 1970 were not). Although our
analysis does not depend upon identifying the systematic
effects underlying the observed seasonality, one might
speculate that, for example, the tendency for a higher than
expected birth rate in September might be related in some
way to the Christmas and New Year holiday season, that is,
it might be primarily a cultural effect.
FIGURE 2: Correlation between the month-specific percent-
age excess in the average normalized daily birth rate (x-
axis) and the prevalence of multiple sclerosis per 100,000
(y-axis) in 16 European countries (Austria, Belgium, Den-
mark, Finland, France, Germany, Greece, Ireland, Italy, the
Netherlands, Norway, Portugal, Spain, Sweden, Switzerland,
and the United Kingdom). (A) Data for April; (B) data for
November. The birth rate estimates were calculated using
the month of birth data sets for the decade 1991–2000.
See the Supplementary Information for more details and for
corresponding figures for other months.
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significant deficit in November (p 5 0.02: Fig 3) are
taken as evidence for consistency. As would be antici-
pated, these results are similar to those reported in the
recent meta-analysis of multiple sclerosis month of birth
studies, which in total considered birth data from
>150,000 cases.16 However, based on the type I error
rates (Fig 4) we calculated using the UK Government
Office Region data (see Subjects and Methods), there is a
high probability that each of these modest residual sig-
nals of apparent association are false positive. Essentially,
because all of the published studies employed simple
unweighted averages of national statistics, none has
adequately matched cases and controls for regional origin
or year of birth, and thus all are likely to demonstrate an
apparent association in keeping with the putative multi-
ple sclerosis pattern by chance alone. The apparent latitu-
dinal gradient in this effect noted in the meta-analysis16
is entirely expected as a reflection of the well-established,
but under-recognized, gradient in seasonality of birth
rates present in the general population.6–8
Discussion
The analyses of genome-wide association studies
(GWASs) have reminded researchers that seemingly ho-
mogeneous populations often turn out to be structured,
and have also shown just how easily such effects are able
to generate false-positive associations even in population-
specific case–control studies (see the example from genet-
ics below). Testing and making compensation for struc-
ture has become an indispensable part of complex
genetics but seems to have been largely ignored in efforts
to explore the possible role of environmental factors in
complex traits. In our analysis of publicly available birth
records, we confirm that birth rate is heterogeneous in
the general population, where it is characterized by sub-
stantial and significant differences both between and
within populations. It follows that birth rates calculated
by the unweighted averaging of available population sta-
tistics are unlikely to provide appropriate controls for
studies of specific diseases, where case collections are
invariably heterogeneous with respect to year of birth
and regional origin. Although it seems logical to average
over many observations to generate more reliable control
estimates, the mean birth rates obtained by such a pro-
cess are a weighted average of the seasonality present in
the population and not an estimate of some fundamental
underlying rate. This weighted mean can only safely be
compared with cases that have the same structure. Self-
evidently, spurious differences will arise if birth rates are
calculated for cases having a different distribution across
subgroups that make up the normal population. Three
groups13,17,18 have considered unaffected siblings as con-
trols in an attempt to avoid such problems. However,
although these related controls are inevitably much better
matched for regional influences, they are necessarily
unmatched for year of birth and are invariably limited in
size and therefore underpowered (see Supplementary
Information and Fig 4).
FIGURE 3: Odds ratio for each month as seen in the original
report from Willer et al13 and in the combined analysis of
published data,13–15,17 together with our own previously
unpublished data (132,241 cases and controls). The
expected (control) counts were as originally reported for
the published data sets and unweighted (ie, crude) for the
new UK data. These odds ratio estimates make no correc-
tion for the temporal and geographical structure in month
of birth that is present in the general population. Months
are coded by their first letters.
FIGURE 4: Lower limit of type I error rates (a) for typical
population-specific multiple sclerosis month of birth studies
of varying size (number of cases 5 number of controls 5 N).
The lower curve indicates a for a discovery study, that is,
the probability of seeing at least 1 month showing a signifi-
cant association after Bonferroni correction (p < 0.05=12 5
0.0042), whereas the upper curve indicates a for a replica-
tion study, that is, the probability of at least 1 spring month
showing a nominally significant (p < 0.05) excess in cases or
at least 1 early winter month showing a nominally significant
(p < 0.05) deficit in cases. These error rates are likely to be
even greater in studies employing cases from >1 country,
especially when these are high-risk (northern) countries such
as Canada, Denmark, and Sweden, but would be reduced in
countries where prevalence is more uniform. See the
Supplementary Information for methodological details.
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The confounding effects described here are a conse-
quence of the substantial geographical and temporal variation
in birth rate that is present in the general population; they are
not specific to multiple sclerosis and have the potential to gen-
erate false-positive association with month of birth in any
study where cases are inadequately matched, regardless of the
phenotype. To date there are>500 reports relating month of
birth to the etiology of a complex trait. The list includes vari-
ous autoimmune diseases (celiac disease,19 diabetes,20 Graves
disease,21 Hashimoto disease,21 inflammatory bowel dis-
ease,22 rheumatoid arthritis,22 and systemic lupus erythema-
tous22), mental health disorders (schizophrenia23 and
suicide24), and health-related traits (birth weight25). Because
almost all of these studies are based on traits that are known to
vary in frequency geographically and they have invariably
used averaged national statistics as their source of controls, it
is likely that many of these apparent associations resulted
from confounding rather than any true biological effect.
The extent of variation in the seasonality of birth
rates and correlation of this phenomenon with latitude
and year of birth are surprising, underappreciated, and dif-
ficult to compensate for fully in the design and analysis of
individual studies. Our observations serve as a reminder
that risk factors that are easy to determine and seemingly
homogenous, such as date of birth, may yet be heteroge-
neous within the general population and therefore generate
false-positive signals if cases and controls are not
adequately matched for the relevant extraneous variables.
Efforts to identify and correct for confounding should be
no less rigorous in the study of environmental risk factors
than are now routine in the field of complex genetics.
Key Points
National birth statistics show that within the general
population: (1) birth rate is subject to highly significant
variation with respect to place and time; and (2) the
probability of being born in the spring (March, April,
and May) is positively correlated with latitude, whereas
the probability of being born in the winter (November,
December, and January) is negatively correlated.
Because typical multiple sclerosis case collections
are unlikely to be uniform with respect to region of ori-
gin or year of birth: (1) studies using national statistics
as controls are predisposed to generate false-positive asso-
ciations with month of birth; and (2) the associations
generated by such studies are inherently biased in favor
of showing a false-positive apparent excess of births in
spring and=or reduced births in winter.
The Effects of Structure: An Example
from Genetics
Confounding due to structure is a well-recognized prob-
lem in complex genetics. Consider the data shown in the
Table, which indicate the total population in each of the
11 Government Office Regions of the United Kingdom
in mid-2010 (Office of national Statistics: http:==www.
ons.gov.uk), together with corresponding multiple sclero-
sis prevalence estimates and the approximate region-
specific frequency of the C allele of the rs1042712 single
nucleotide polymorphism (SNP) from the lactase gene
(taken from Fig 7 of the supplementary file of the Well-
come Trust Case Control Consortium Genome Wide
Association Study).26 Inspection of the Table shows that
both the prevalence of multiple sclerosis and frequency
of the C_rs1042712 allele vary geographically; prevalence
correlates positively with latitude, whereas allele fre-
quency is negatively correlated. Despite absolute differen-
ces in allele frequency only amounting to a few
percentage points, the resulting structure is sufficient to
confound association studies if ignored, and the UK pop-
ulation is wrongly assumed to be homogenous with
respect to the frequency of this allele.
If controls are randomly selected from across the
United Kingdom (as, for example, they would tend to
be in a birth cohort), the expected allele frequency is
11.6%, less than is seen in London (14.5%) and more
than in Wales (9.5%). If an association study were
performed in London using 10,000 such controls and
2,000 local patients, it would find nominally signifi-
cant evidence (p < 0.05) that C_rs1042712 is a risk
factor for multiple sclerosis, with >99.9% certainty,
and would generate a genome-wide significant result
(p < 5 3 1028) >40% of the time. If the study were
then repeated using a similar design but with 2,000
patients from the East of England Government Office
Region, the apparent association would be replicated
with 1-tailed nominal significance on the majority of
occasions (>90%). Conversely, if replication were
attempted in Wales, researchers would most likely
(>95%) find nominally significant evidence that
C_rs1042712 appears protective. The ease with which
apparently significant results can be generated despite
the relatively modest absolute difference in allele fre-
quency illustrates how sensitive case–control analysis is
to unrecognized, and therefore uncompensated, popu-
lation structure.
Even if everyone in the UK population were geno-
typed for the rs1042712 SNP, enabling all cases to be
compared with all controls, nominally significant evi-
dence that C_rs1042712 is associated (protective) would
be observed on >95% of occasions. This bias arises
because a disproportionate number of the cases will
come from northern (high prevalence) parts of the coun-
try, which generally have a lower than average allele fre-
quency for this particular SNP; as a result the estimated
ANNALS of Neurology
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allele frequency in cases will tend to be lower (11.3%)
than in the general population (11.6%). This illustrates
why, even if all cases and all controls from a country are
included in an analysis, structure can still generate false-
positive associations unless there is compensation for the
confounding effects of their unequal distribution.
Whether a study that only employs cases and controls
from a single Government Office Region would be free
from bias cannot be judged from the figures provided in
the Table. Given the highly significant difference in both
disease and allele frequency between regions, it seems
probable that structure will also occur within, although
to a lesser extent than between, regions.
Genetic analyses are uniquely well placed with
respect to the assessment and compensation of structure.
First, although the above analysis has considered matters
from a geographical perspective, the primary confound-
ing variable in genetic studies is ancestry, not geography.
The probability that individuals carry a particular allele
of interest primarily depends upon who their ancestors
were and not where they were born or domiciled when
recruited to a study. Because ancestry does not change
over time, and can be accurately inferred using genetic
markers, in principle little if any geographical precision is
necessary to assess and correct for structure in allele fre-
quency distribution within a population. Conversely, for
social and mobility reasons, there is an inevitable correla-
tion between geography and ancestry,27 and this
relationship means that geography often provides a rea-
sonable, and useful, surrogate for ancestry as illustrated
above. Second, because GWASs typically include many
thousands of markers that are not associated with the
particular disease of interest, these additional neutral data
allow researchers both to measure28 and to compensate
for differences in the ancestry of cases and controls.29 By
comparing allele frequency distributions across regions of
the United Kingdom, the Wellcome Trust Case Control
Consortium established that most common variants show
little variation in allele frequency within populations, the
rs1042712 SNP from the lactase gene being 1 of only a
limited number of exceptions to this rule.26 Available evi-
dence suggests that this SNP is part of a haplotype that
has been subject to considerable selection in the recent
past and hence is now highly structured in the popula-
tion.30 However, for the vast majority of common var-
iants studied in GWASs, there is only limited structure
within and between populations, and this can usually be
compensated for using ancestral information from the
thousands of unassociated markers that are inevitably
typed as part of a GWAS.
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